Guidance

COVID-19: rapid tests for use in community pharmacies or at home

Advice on the use of rapid point of care tests for COVID-19.

This publication was withdrawn on

This guidance has been superseded by information available at: COVID-19: rapid point of care (near-person) testing for service providers

Documents

Details

Some manufacturers are selling products for the diagnosis of COVID-19 infection in community settings, such as pharmacies. The current view by PHE is that use of these products is not advised.

Published 15 March 2020
Last updated 11 May 2020 + show all updates
  1. Clarification that these are rapid point of care tests, different from those offered as part of testing for essential workers.

  2. First published.